Biotechnology
- CNBC's Becky Quick details daughter's rare disease journey - CNBC Squawk Box anchor Becky Quick details her daughter's rare disease journey, and explains why it inspired her to launch CNBC Cures.
- UnitedHealth Group commits to improvements after independent audit, patient backlash - The company said it has adopted 23 ongoing "action plans" to track and implement recommended improvements, all of which will be completed by the end of March.
- Trump signs executive order reclassifying cannabis, opening door to broader weed access - President Donald Trump signed an executive order Thursday reclassifying marijuana as a Schedule III substance with looser restrictions.
- Medical supply firm Medline jumps more than 25% in debut after biggest IPO of 2025 - Medline priced at $29 per share on Tuesday, raising $6.26 billion to cap off a strong year for new listings and bolster optimism about 2026.
- Eli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial - The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill.
- 'Terrifying': Why U.S. senator in top intel post wants more spying on Chinese companies - Chinese biotech BGI will pass Huawei in scale and threat, says Sen. Mark Warner. 'It's terrifying,' he said at CNBC event, pushing for more corporate spying.
- RFK Jr.'s vaccine panel to vote on changing hepatitis B shot recommendation for babies - The current recommendation for babies to receive a hepatitis B shot within 24 hours of birth is credited with driving down infections in kids by 99%.
- Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site - The announcement comes weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to access.